NOTCH3 and Osteopenia: The results confirm observations reported in mouse models of LMS termed Notch3em1Ecan that presented with a NOTCH3 gain-of-function and osteopenia secondary to an increase in receptor activator of NF-κB ligand (RANKL) in cells of the osteoblast lineage [38].